The PstI/RsaI and DraI polymorphisms of <it>CYP2E1 </it>and head and neck cancer risk: a meta-analysis based on 21 case-control studies
<p>Abstract</p> <p>Background</p> <p><it>CYP2E1 </it>encodes a member of the cytochrome P450 superfamily of enzymes which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-10-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/10/575 |